Gene Therapy Approach for Intervertebral Disc Degeneration: An Update

Area of Science:

• Regenerative Medicine
• Molecular Biology
• Biotechnology

Background:

• Intervertebral disc degeneration is a primary cause of back pain and neurological disorders.
• Current surgical treatments for disc degeneration involve disc excision, leading to functional loss and biomechanical complications.
• Gene therapy presents a potential alternative for treating degenerative disc disease due to its capacity for long-lasting therapeutic effects.

Purpose of the Study:

• To review the backgrounds and applications of gene therapy for intervertebral disc degeneration.
• To introduce strategies for modulating autophagy and mammalian target of rapamycin (mTOR) signaling via gene therapy.
• To highlight the potential of RNA interference and CRISPR systems in treating disc degeneration.

Main Methods:

• Review of existing literature on gene therapy for intervertebral disc degeneration.
• Discussion of viral and nonviral vector applications in gene delivery to the disc.
• Exploration of RNA interference and CRISPR-Cas9 systems for gene modulation.
• Focus on targeting autophagy and mTOR signaling pathways.

Main Results:

• Gene therapy, utilizing viral and nonviral vectors, can be applied to the intervertebral disc.
• RNA interference enables specific gene downregulation, while CRISPR systems offer gene editing capabilities for disc degeneration.
• Autophagy and mTOR signaling have been identified as key targets for gene therapy interventions in the disc.

Conclusions:

• Gene therapy, particularly through modulation of autophagy and mTOR signaling, holds significant potential for treating intervertebral disc degeneration.
• Selective RNA interference offers a viable strategy for targeting these pathways.
• Further research into gene therapy approaches can lead to improved treatments for back pain and associated neurological conditions.